BACKGROUND & AIMS: There is a clinical need for methods that can quantify regional
hepatic function non-invasively in patients with cirrhosis. Here we validate the use of 2-[ 18 F]…

Methods Nine cirrhotic patients underwent dynamic liver FDGal PET/CT with blood samples
from a radial artery and liver vein. Hepatic blood flow was measured by indocyanine green …

The galactose analog 2- 18 F-fluoro-2-deoxy-d-galactose ( 18 F-FDGal) is a suitable PET
tracer for measuring hepatic galactokinase capacity in vivo, which provides estimates of …

… decompensated cardiac failure (DCF), as defined clinically and echocardiogram LVEF<40%;
patients undergoing right heart catheter (RHC) with pulmonary hypertension ± CCF at St Vincent’s …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety …

… with chronic obstructive pulmonary disease (COPD) and comorbid GAD or panic disorder
indicate that such treatment may improve both the physical and mental health (Mikkelsen et al. …

… S. Kasper received grants/research support, consulting fees and/or honoraria within the
last three years from Angelini, AOP Orphan Pharmaceuticals AG, Celgene GmbH, Eli Lilly, …

… Escitaloprarn, the S-enantiomer of citalopram, was effective in a DBPC study in social
anxiety disorder, but this study has not yet been published (Kasper et a1 2002b). Although a …

We examined the relationship between plasma concentrations of specific acting
antidepressants (fluvoxamine/maprotiline) and clinical improvement as well as the impact of the …

… Without any relevance to this work, S. Kasper declares that he has received grant/research
support from Eli Lilly, H. Lundbeck A/S, Bristol-Myers Squibb, Servier, Sepracor, …